195 related articles for article (PubMed ID: 30893335)
1. Optimal regulation of blood glucose level in Type I diabetes using insulin and glucagon.
Shirin A; Della Rossa F; Klickstein I; Russell J; Sorrentino F
PLoS One; 2019; 14(3):e0213665. PubMed ID: 30893335
[TBL] [Abstract][Full Text] [Related]
2. Role of Dual-Hormone Closed-Loop Delivery System in the Future.
Bally L; Thabit H; Hovorka R
Diabetes Technol Ther; 2016 Aug; 18(8):452-4. PubMed ID: 27500812
[No Abstract] [Full Text] [Related]
3. The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes.
Heptulla RA; Rodriguez LM; Bomgaars L; Haymond MW
Diabetes; 2005 Apr; 54(4):1100-7. PubMed ID: 15793249
[TBL] [Abstract][Full Text] [Related]
4. Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial.
Abitbol A; Rabasa-Lhoret R; Messier V; Legault L; Smaoui M; Cohen N; Haidar A
Diabetes Technol Ther; 2018 Mar; 20(3):189-196. PubMed ID: 29393675
[TBL] [Abstract][Full Text] [Related]
5. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
[TBL] [Abstract][Full Text] [Related]
6. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
Pickup JC
Diabetes Technol Ther; 2011 Jul; 13(7):695-8. PubMed ID: 21668344
[No Abstract] [Full Text] [Related]
7. The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.
Gingras V; Taleb N; Roy-Fleming A; Legault L; Rabasa-Lhoret R
Diabetes Obes Metab; 2018 Feb; 20(2):245-256. PubMed ID: 28675686
[TBL] [Abstract][Full Text] [Related]
8. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
[TBL] [Abstract][Full Text] [Related]
9. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
[TBL] [Abstract][Full Text] [Related]
10. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
[TBL] [Abstract][Full Text] [Related]
11. In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.
Wood MA; Shulman DI; Forlenza GP; Bode BW; Pinhas-Hamiel O; Buckingham BA; Kaiserman KB; Liljenquist DR; Bailey TS; Shin J; Huang S; Chen X; Cordero TL; Lee SW; Kaufman FR
Diabetes Technol Ther; 2018 Nov; 20(11):731-737. PubMed ID: 30299976
[TBL] [Abstract][Full Text] [Related]
12. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
Ranjan A; Wendt SL; Schmidt S; Madsbad S; Holst JJ; Madsen H; Knudsen CB; Jørgensen JB; Nørgaard K
Basic Clin Pharmacol Toxicol; 2018 Mar; 122(3):322-330. PubMed ID: 28922582
[TBL] [Abstract][Full Text] [Related]
13. Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
Tsuchimochi W; Ueno H; Yamashita E; Tsubouchi C; Sakoda H; Nakamura S; Nakazato M
Endocr J; 2015; 62(1):13-20. PubMed ID: 25252844
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Basal Insulin Suspension at the Start of Exercise on Blood Glucose Levels During Continuous Versus Circuit-Based Exercise in Individuals with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion.
Zaharieva D; Yavelberg L; Jamnik V; Cinar A; Turksoy K; Riddell MC
Diabetes Technol Ther; 2017 Jun; 19(6):370-378. PubMed ID: 28613947
[TBL] [Abstract][Full Text] [Related]
15. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.
Lee SW; Cao M; Sajid S; Hayes M; Choi L; Rother C; de León R
Diabetes Nutr Metab; 2004 Aug; 17(4):211-6. PubMed ID: 15575341
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant Liraglutide and Insulin Versus Insulin Monotherapy in the Closed-Loop System in Type 1 Diabetes: A Randomized Open-Labeled Crossover Design Trial.
Ilkowitz JT; Katikaneni R; Cantwell M; Ramchandani N; Heptulla RA
J Diabetes Sci Technol; 2016 Sep; 10(5):1108-14. PubMed ID: 27184690
[TBL] [Abstract][Full Text] [Related]
17. Implications of Predictive Low-Glucose Management System in Hybrid of Full Closed Loop System.
Choudhary P
Diabetes Technol Ther; 2016 Jul; 18(7):408-9. PubMed ID: 27379979
[No Abstract] [Full Text] [Related]
18. Dual-hormone treatment with insulin and glucagon in patients with type 1 diabetes.
Reiband HK; Schmidt S; Ranjan A; Holst JJ; Madsbad S; Nørgaard K
Diabetes Metab Res Rev; 2015 Oct; 31(7):672-9. PubMed ID: 25533565
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
20. A new index to optimally design and compare continuous glucose monitoring glucose prediction algorithms.
Facchinetti A; Sparacino G; Trifoglio E; Cobelli C
Diabetes Technol Ther; 2011 Feb; 13(2):111-9. PubMed ID: 21284477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]